A “misleading and false” message. The author of the message says that the prestigious American daily has ranked four Chinese vaccines at the top of the safest Covid-19 vaccines, ahead of those developed by Astra-Zeneca, Pfizer, and Moderna.
The false classification, written in broken English, places two vaccines designed by Sinopharm in the lead. Next came vaccines from Kexing, a company also known as Sinovac, and CanSino Biologics. Russian vaccine closes the list.
The false message states that ” China has exported more than 500 million doses of vaccines to more than 50 countries.”
The New York Times communications team has denied the content of this message. The newspaper “has not published this list, our articles have not suggested that Chinese vaccines are superior to vaccines produced elsewhere, and we have not published claims that China has exported more than 500 million doses ”.
There is no record of such a list on the newspaper’s website. If a mention of 500 million doses does indeed appear in an article of December 9, it is not to say that China exported this half a billion. The New York Times, quoting info from a Chinese newspaper, argued that the Sinopharm company was preparing to deliver these doses to the whole world.
The four Chinese vaccines mentioned in the list are in phase three of clinical trials, according to the American journal, which specifies that the data from these trials have not yet been published in scientific journals. These vaccines have not yet obtained marketing authorization in the EU and the United States.